The carnosinase dipeptidase CNDP1 is a novel metabolic vulnerability in brain metastasis
Gomez-Munoz, M. A.; Karz, A.; Navarro, M.; Osorio-Vasquez, V. M.; Katsara, O.; Walker, A.; Berico, P.; Medellin, A. P.; Eskow, N. M.; Wan, Y.; Ibrahim, M.; Tagore, S.; DSouza, E. K.; Izar, B.; Vega-Saenz de Miera, E.; Osman, I.; Pacold, M.; Kong, X.; Levesque, M.; Possemato, R.; Holmen, S.; Schneider, R.; Vincent, T.; Ruggles, K.; Biancur, D.; Hernando, E.
Show abstract
Brain metastatic cells undergo metabolic adaptations, such as increased reliance on oxidative phosphorylation. Integrating proteomic and transcriptomic profiling of patient samples revealed a consistent upregulation of the carnosine dipeptidase-1 (CNDP1) in brain versus extracranial metastases. Carnosine is an abundant metabolite in brain and muscle, known to exert anti-proliferative effects on cancer cells. Here, we demonstrate that CNDP1 inhibition suppresses both the establishment and maintenance of melanoma brain metastasis while its ectopic expression is sufficient to confer brain metastatic potential to poorly metastatic cells. CNDP1 suppression results in activation of the Integrated Stress Response via Heme-Regulated Inhibitor Kinase and reprogrammed translation towards preferential expression of mitochondrial and survival transcripts. We further show that CNDP1 upregulation supports mitochondrial activity by limiting the levels of its substrate carnosine, a copper ionophore, thus protecting metastatic cells from carnosine-induced copper toxicity. Our studies reveal a novel metabolic adaptation during brain metastasis, which can be leveraged for therapeutic purposes.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Melanoblast transcriptome analysis reveals novel pathways promoting melanoma metastasis 97%
- MaTAR25 LncRNA Regulates the Tensin1 Gene to Impact Breast Cancer Progression 97%
- Anti-CSF-1R therapy with combined immuno- chemotherapy coordinate an adaptive immune response to eliminate macrophage enriched Triple Negative Breast Cancers 96%
Similar papers in this journal
- Metabolic reprogramming of cancer cells by JMJD6-mediated pre-mRNA splicing is associated with therapeutic response to splicing inhibitor 96%
- SDR enzymes oxidize specific lipidic alkynylcarbinols into cytotoxic protein-reactive species 96%
- NAB2-STAT6 drives an EGR1-dependent neuroendocrine program in Solitary Fibrous Tumors 96%
Similar papers in this journal
- Targeting EIF4A triggers an interferon response to synergize with chemotherapy and suppress triple-negative breast cancer 96%
- Integrative analysis reveals therapeutic potential of pyrvinium pamoate in Merkel cell carcinoma 96%
- Tumor cell-derived spermidine promotes a pro-tumorigenic immune microenvironment in glioblastoma via CD8+ T cell inhibition 96%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.